Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Sensory Walkway and Gait in Children With Diplegic Cerebral Palsy (SWGCP)

15 mai 2026 mis à jour par: Eman Mostafa Fathallah Elsharawy, Cairo University

Effect of Sensory Walkway on Gait Parameters in Children With Diplegic Cerebral Palsy

This study aims to evaluate the effect of sensory walkway training on gait performance in children with spastic diplegic cerebral palsy. Participants will be assigned to a control group receiving conventional physical therapy or an intervention group receiving conventional therapy combined with sensory walkway training. The intervention will be conducted over a defined treatment period.

Aperçu de l'étude

Statut

Recrutement

Les conditions

Intervention / Traitement

Description détaillée

This study will be conducted after approval from the Ethical Committee of the Faculty of Physical Therapy, Cairo University, and will follow the ethical principles of the Declaration of Helsinki. Written informed consent will be obtained from the parents of all participating children.

The intervention involves the use of a structured sensory walkway composed of eight wooden foot boxes filled with different textured materials, including polyester fiberfill, cut plastic straws, foam beads, and kinetic sand. This setup is designed to provide continuous multimodal tactile stimulation during gait training to enhance sensory-motor integration, postural control, and gait performance. Children in the intervention group will perform reciprocal gait training while interacting with the sensory surfaces, accompanied by verbal feedback to facilitate sensory awareness and motor engagement.

Both groups will receive a traditional physical therapy program including stretching exercises, quadruped and kneeling activities, balance training, stepper exercises, and gait training on various surfaces and equipment.

Data will be analyzed using descriptive statistics (mean and standard deviation), and statistical analysis will be performed using IBM SPSS software.

Type d'étude

Interventionnel

Inscription (Estimé)

44

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

  • Egypte
    • Giza Governorate
      • Dokki, Giza Governorate, Egypte
        • Recrutement
        • outpatient clinic, faculty of physical therapy, Cairo university
        • Contact:
        • Sous-enquêteur:
          • Shaymaa Rushdy Mahmoud, Lecturer of Physical Therapy

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Enfant

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Clinical diagnosis of spastic diplegic cerebral palsy
  • Aged between 5 and 7 years
  • Classified at level II on the Gross Motor Function Classification System
  • Spasticity grade 1 or 1+ according to the Modified Ashworth Scale
  • Able to walk independently or with an assistive device without physical assistance
  • Able to follow verbal commands
  • Abnormal gait pattern

Exclusion Criteria:

  • Visual or auditory impairment
  • History of lower limb surgery within the past 2 years
  • Use of medications affecting muscle tone and/or cognitive function
  • Contractures or fixed deformities in upper or lower limbs

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Non randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Control Group - Conventional Physical Therapy
Participants in the control group will receive a conventional physical therapy program including stretching exercises for lower limb muscles, strengthening exercises, balance training, and gait training. The program includes quadruped exercises, kneeling and half-kneeling positions, standing balance exercises using balance boards and beams, stepping exercises, and walking training using parallel bars and assistive devices. Each session lasts 60 minutes and will be conducted three times per week for three consecutive months.
Comportemental: Conventional Physical Therapy Program
Participants in the control group will receive a conventional physical therapy program including stretching exercises for lower limb muscles, strengthening exercises, balance training, and gait training. The program includes quadruped exercises, kneeling and half-kneeling positions, standing balance exercises using balance boards and beams, stepping exercises, and walking training using parallel bars and assistive devices. Each session lasts 60 minutes and will be conducted three times per week for three consecutive months.
Expérimental: Study Group - Conventional Physical Therapy plus Sensory Walkway Training
Participants in the study group will receive conventional physical therapy including stretching, strengthening, balance exercises, and gait training. In addition, they will undergo gait training on a sensory walkway consisting of wooden foot boxes filled with different textured materials to provide tactile stimulation. Corresponding hand sensory boxes are placed along parallel bars to provide simultaneous upper limb sensory input. Children will walk through the walkway while immersing their feet and hands in the textured materials and are encouraged to identify and describe textures to enhance sensory awareness. The intervention aims to improve sensory-motor integration, postural control, balance, and gait parameters in children with spastic diplegic cerebral palsy. Each session lasts 60 minutes and is performed three times per week for three months.
Comportemental: Conventional Physical Therapy Program
Participants in the control group will receive a conventional physical therapy program including stretching exercises for lower limb muscles, strengthening exercises, balance training, and gait training. The program includes quadruped exercises, kneeling and half-kneeling positions, standing balance exercises using balance boards and beams, stepping exercises, and walking training using parallel bars and assistive devices. Each session lasts 60 minutes and will be conducted three times per week for three consecutive months.
Comportemental: Sensory Walkway Training
Participants in the study group will receive conventional physical therapy in addition to gait training on a sensory walkway. The sensory walkway consists of a sequence of wooden foot boxes filled with different textured materials to provide tactile stimulation of the feet during walking. Corresponding hand sensory boxes are placed along parallel bars to provide simultaneous upper limb sensory input. This setup enables reciprocal sensory stimulation of upper and lower limbs during gait training. Children will walk through the walkway in a controlled manner while immersing their feet and hands in the textured materials and are encouraged to identify and describe the textures to enhance sensory awareness. The intervention aims to improve sensory-motor integration, postural control, balance, and gait parameters in children with spastic diplegic cerebral palsy. Each session lasts 60 minutes and is performed three times per week for three months.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Gait Speed
Délai: 3 months
Gait speed (m/s) will be assessed using the 10-Meter Walk Test (10MWT). Participants will walk a 10-meter distance at a self-selected comfortable walking speed. Time recorded during the test will be used only to calculate gait speed.
3 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Step Width
Délai: 3 months
Step width (cm) will be assessed using Kinovea software based on video recordings.
3 months
Cadence
Délai: 3 months
Cadence (steps/min) will be calculated using gait cycle analysis from Kinovea software
3 months
Step Time
Délai: 3 months
Step time (seconds) will be analyzed using Kinovea software based on video-based gait cycle timing.
3 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Cairo University

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 mars 2026

Achèvement primaire (Estimé)

30 décembre 2026

Achèvement de l'étude (Estimé)

31 janvier 2027

Dates d'inscription aux études

Première soumission

8 mai 2026

Première soumission répondant aux critères de contrôle qualité

15 mai 2026

Première publication (Réel)

19 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

19 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

15 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Mots clés

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • No:P.T.REC/012/006158

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be shared to protect participants' privacy and confidentiality. The data collected in this study will be used for research purposes only and will not be publicly available.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner